Keros Therapeutics (KROS) Change in Taxes (2025)
Keros Therapeutics posted quarterly Change in Taxes of -$1.9 million for Q4 2025, up 12.74% on a QoQ basis from -$2.2 million in Q3 2025.
Keros Therapeutics (KROS) has 1 years of Change in Taxes data on file, last reported at -$1.9 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Taxes changed N/A year-over-year to -$1.9 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (changed N/A YoY), and the FY2025 full-year result was $2.2 million, changed N/A from the prior year.
- Change in Taxes for Q4 2025 stood at -$1.9 million, up from -$2.2 million in the prior quarter.
- Across five years, Change in Taxes topped out at $10.0 million in Q1 2025 and bottomed at -$3.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -1.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.90 Mn |
| Dec 31, 2025 | -1.90 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Sep 30, 2025 | -2.17 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -3.72 Mn |
| Mar 31, 2025 | 10.04 Mn |
| Mar 31, 2025 | 10.04 Mn |